NDC 49702-243 - Cabenuva
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49702-243
- Package NDCs from labels
- 49702-243-02, 49702-243-61
- Manufacturer
- ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV
- Effective date
- 2025-11-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cabenuva - ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV | ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV | 2025-11-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49702-243-02 | Cabenuva | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 300 mg in 1mL | 16 |
| 49702-243-61 | Cabenuva | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 300 mg in 1mL | 16 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Polyethylene Glycol 3350 Powder for Solution | POLYETHYLENE GLYCOL, UNSPECIFIED | VALLEY MEDICAL PRODUCTS, LLC | ae595e97-6d29-44f8-a647-fcd54fcda5b1 | 2025-10-27 | Warnings | G2M7P15E5P |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| NORMOSOL-M AND DEXTROSE | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM ACETATE, AND MAGNESIUM ACETATE | ICU Medical Inc. | aba60c84-94d9-46d0-bdbb-25e0c4e8cc41 | 2025-10-24 | Warnings, Adverse reactions | LX22YL083G |
| Polyethylene glycol 3350 | POLYETHYLENE GLYCOL 3350 | Cardinal Health 107, LLC | 2f5c975f-0d35-4f68-a27c-28af9a898733 | 2025-10-23 | Warnings | G2M7P15E5P |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Me NaPhos MB Hyo 1 | URINARY ANTISEPTIC ANTISPASMODIC | Method Pharmaceuticals | 2ae628e7-3b33-6a9a-e054-00144ff8d46c | 2025-10-21 | Warnings, Adverse reactions | 593YOG76RN |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical Inc. | cdf35d11-fbc8-4f8e-85a8-33220312c0b4 | 2025-10-17 | Warnings, Adverse reactions | LX22YL083G |
| MiraLAX | POLYETHYLENE GLYCOL 3350 | ASCLEMED USA INC. | e652042f-3707-4bf6-831d-d806638b7d85 | 2025-10-14 | Warnings | G2M7P15E5P |
| Laxative | POLYETHYLENE GLYCOL 3350 | Rite Aid Corporation | 457f5d2d-4595-482a-9ffa-659fb5d5b134 | 2025-10-09 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Bryant Ranch Prepack | 5df518fb-ad58-4f17-af34-f66066f1313a | 2025-09-30 | Warnings | G2M7P15E5P |
| Dulcolax | POLYETHYLENE GLYCOL 3350 | Chattem, Inc. | ed16d0f4-74e7-4fa3-989d-c6840a5d3e71 | 2025-09-30 | Warnings | G2M7P15E5P |
| Xpect Eyewash | EYEWASH | Cintas Corporation | 1d69365d-662b-4248-8fa9-1629451b549a | 2025-09-30 | Warnings | 059QF0KO0R |
| CheBoho TEA TREE ACNE | CHEBOHO TEA TREE ACNE | Opalshi(Guangzhou)E-commerce Co. Ltd. | 3fc4cf84-b2da-c593-e063-6394a90abc5c | 2025-09-27 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | ProPharma Distribution | 3f2ae880-852f-b45d-e063-6394a90aa1cc | 2025-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| kirkland signature laxaclear original prescription strength | POLYETHYLENE GLYCOL 3350 | Costco Wholesale Company | f58fa5c0-8ab7-4427-aea0-d536b47acbb5 | 2025-09-18 | Warnings | G2M7P15E5P |
| up and up powderlax | POLYETHYLENE GLYCOL 3350 | Target Corporation | 1bceb457-b24f-485d-bfe2-af4b7d38a5c2 | 2025-09-18 | Warnings | G2M7P15E5P |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | LX22YL083G |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | LX22YL083G |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | LX22YL083G |
| GAVILYTE-N | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | Lupin Pharmaceuticals,Inc. | 27195187-75a3-431f-90d9-84da1b94e849 | 2025-09-10 | Warnings, Adverse reactions | G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.